Bart Jan Kullberg

Bart Jan Kullberg is a Professor of Medicine and Infectious Diseases at Radboud University Nijmegen, a position he has held since 2003. He chairs the Netherlands’ national fungal treatment guidelines committee and the nationwide antimicrobial stewardship program. His career spans leadership roles in clinical research, education, and policy development.

• MD from Leiden University (1982)
• PhD from Leiden University (1992) focusing on host resistance to Candida albicans

His research focuses on invasive fungal infections, Lyme disease, and antimicrobial stewardship. He has pioneered studies on the pathogenesis of candidiasis, the role of genetic mutations in host defense, and the efficacy of prolonged antibiotic treatment for Lyme disease. His work bridges clinical trials, immunogenetics, and evidence-based guidelines.

Professor Kullberg’s recent publications emphasize antifungal therapy, genetic susceptibility to infections, and antimicrobial stewardship. Collaborative efforts with organizations like the Mycoses Study Group (MSG) and the Netherlands Centre of Expertise on Lyme Disease underscore his interdisciplinary approach.

• Member of the Health Council of the Netherlands (2015)
• Elected Fellow, Royal College of Physicians (London) (2009)
• Elected Fellow, Infectious Diseases Society of America (2005)

He has co-authored over 386 peer-reviewed publications with an h-index of 77. His leadership in clinical trials and guideline committees, including contributions to the New England Journal of Medicine and Nature Reviews Disease Primers, highlights his global authority in infectious diseases.